SCHEMBL4987232

SCHEMBL4987232

COc1ccc(-n2nc(C(=O)NC(C)(C)C)nc2-c2ccc(C#N)cn2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.40
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
OXTR P30559 4/20 0.37
AVPR1A P37288 3/20 0.37
NR3C1 P04150 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SRC P12931 1/20 0.35
SYK P43405 1/20 0.35
MAPK12 P53778 1/20 0.35
PTGS2 P35354 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4987252 0.89 OXTR (0.38) ALDH1A1NPSR1KDM4EHPGDOXTR
SCHEMBL4990555 0.89 MEN1 (0.38) ARMEN1NPC1RAB9AKMT2A
SCHEMBL4986965 0.88 OXTR (0.39) ALDH1A1NPSR1KDM4EHPGDOXTR
SCHEMBL4987655 0.87 P2RX7 (0.39) OXTRAVPR1ANR3C1MEN1NPC1
SCHEMBL4990279 0.87 AR (0.37) AROXTRMEN1NPC1RAB9A
SCHEMBL4984634 0.87 MEN1 (0.37) ARMEN1NPC1RAB9AKMT2A
SCHEMBL4988506 0.86 OXTR (0.40) ALDH1A1NPSR1KDM4EHPGDOXTR
SCHEMBL4990274 0.85 MEN1 (0.38) AROXTRAVPR1AMEN1NPC1
SCHEMBL4984731 0.84 RAB9A (0.45) ARALDH1A1KDM4EMEN1NPC1
SCHEMBL4990652 0.84 HPGDS (0.40) ALDH1A1KDM4EHPGDNR3C1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-05-29 US disclosed
EP-1803719-A1 1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125409-A1 1,5-Diheterocycle-1H-Triazole Derivative PTGS1, PTGER1, TBXA2R AR 304/4885ALDH1A1 185/4885NPSR1 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.